Demonstrates engineered synthetic cells that show transport properties with programmed growth and viscoelastic environments, indicating potential for new metabolic systems.
Liquid-liquid phase separation of nucleic acids has emerged as a powerful route to engineer synthetic cells. Condensates of single-stranded DNA provide programmable, viscoelastic environments that mimic aspects of the cytoplasm while offering precise sequence-level control. Within these DNA-based synthetic cells, we exploit secondary structures to assemble artificial cytoskeletons, uncover non-Fickian uptake and transport, and integrate catalysts and DNAzymes to establish metabolism-driven adaptive behaviors. In parallel, we have recently demonstrated that RNA condensates can be built de novo by transcriptional activity, using KL-motif RNAs to nucleate and sustain dynamic compartments. These RNA-based condensates offer a direct bridge between genetic information processing and compartmentalization, enabling the creation of synthetic organelles whose growth and properties are encoded by transcriptional programs.
No takes yet. Share an insight, caveat, or question.
Andreas Walther (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: